TNFRSF10A and cancer: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a cytokine considered as a promising anticancer agent as binding of TRAIL to its receptors, death receptor 4 (DR4) and death receptor 5 (DR5) initiates apoptosis in various cancer cell types without affecting normal cells [88,89].